Word

PENTEC HEALTH

Status

Pending

Status Code

681

Status Date

Wednesday, April 10, 2024

Serial Number

97881034

Mark Type

4000

Filing Date

Monday, April 10, 2023

Published for Opposition

Tuesday, May 14, 2024

Trademark Owner History

Pentec Health, Inc.

Classifications

41 Educational services, namely, providing educational seminars to industry healthcare professionals in the field of care of patients suffering from chronic kidney disease (CKD), end stage renal disease (ESRD), diabetes, intractable pain, and spasticity conditions, gastrointestinal disorders, clinical nutrition deficiencies related to chronic diseases, and cancer

5 Oral nutritional supplements; dietetic foods adapted for medical use; parenteral nutrition delivered intravenously to treat patients with clinical nutritional deficiences; enteral nutrition formulas used to treat individuals with inborn errors of metabolism and metabolic conditions; vials containing compounded sterile preparations in the nature of sterile pharmaceutical preparations for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; syringes containing compounded sterile preparations in the nature of sterile pharmaceutical preparations for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients

36 Providing information regarding health care claim insurance, claim information, and payment options to health care providers, insurers, and consumers

35 Pharmaceutical services, namely, processing prescription drug orders in closed-door, sterile, compounding pharmacies; specialized closed-door, sterile, compounding pharmacy services, namely, processing prescription drug orders for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; consulting services, namely, providing consumer information about health care plans

44 Pharmaceutical advice for renal clinics, pain and spasticity management physician practices, nephrologists, dietitians, and oncologists; specialized closed-door, sterile, compounding pharmacy services, namely, pharmaceutical compounding services for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; healthcare, namely, providing specialty infusion therapy for renal patients, wound care patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, pain and spasticity patients, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; providing healthcare services featuring supplemental oral nutrition therapy, nutrition therapy, nutrition counseling, and medical food therapy programs to patients and healthcare providers; Health care services for treating patients with clinical nutrition deficiencies by providing medical food formulated for administration under medical supervision

HEALTH

Trademark Events

Apr 9, 2024

Approved For Pub - Principal Register

Apr 9, 2024

Examiner's Amendment Entered

Apr 9, 2024

Notification Of Examiners Amendment E-Mailed

Apr 9, 2024

Examiners Amendment E-Mailed

Apr 9, 2024

Examiners Amendment -Written

Apr 6, 2024

Teas/Email Correspondence Entered

Apr 4, 2024

Correspondence Received In Law Office

Apr 4, 2024

Teas Response To Office Action Received

Jan 5, 2024

Notification Of Non-Final Action E-Mailed

Jan 5, 2024

Non-Final Action E-Mailed

Jan 5, 2024

Non-Final Action Written

Jan 5, 2024

Assigned To Examiner

May 4, 2023

New Application Office Supplied Data Entered

Apr 13, 2023

New Application Entered